First-in-class NVL inhibitors starve tumors by blocking ribosome assembly
Researchers have developed the first selective inhibitors of the NVL ATPase, blocking 60S ribosomal subunit assembly to activate p53 and ...
Researchers have developed the first selective inhibitors of the NVL ATPase, blocking 60S ribosomal subunit assembly to activate p53 and ...
Researchers have identified the first small-molecule activators of the Staphylococcus aureus ClpC/ClpP protease, mapping two druggable regulatory sites that could ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine